LinKinVax logo


See LinKinVax's full profile



Founded Year


Total Funding


1 - 10



About LinKinVax

LinKinVax is a French biotechnology startup that focuses on speeding up vaccine development by bringing together basic science and industrial processes.



General Information on LinKinVax

Brand name LinKinVax
Company name Linkinvax Europe SAS
Founded year 2020
Employees 1 - 10
Founding team

Andre-Jacques Auberton-Herve

Contact [email protected]

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.

Recent News and Activity about LinKinVax

StreetInsider 04.05.2022
LinKinVax Appoints Dr. Jiong Ma as Independent Board Member

brings over 25 years of experience in investing, building, and scaling technology companies. Based in the United States, she served as Senior Partner and a member of the investment committee at Braemar Energy Ventures, leading investments in resource efficiency, e-mobility, industrial digitalization, renewable energy, and deep tech. She is founder and board of director of Chavant Capital Acquisition Corp. (Nasdaq: CLAY ). Ms. Ma serves on the ...

LinKinVax news 16.03.2022
LinKinVax collaborates with GTP Bioways for development & production of its second-generation vaccine to prevent Covid-19

With this collaboration, the two companies are strengthening a partnership that initially focused on developing products from the VRI/INSERM vaccine platform, which LinKinVax is now exploiting under an exclusive global licence. The agreement with GTP Bioways relates to the development of a new vaccine, from development of the cell line to production of a clinical batch to be tested in a clinical trial. LinKinVax’s innovative technology is based ...

StreetInsider 12.02.2022
LINKINVAX Raises €4.350 Million in Funding

It was led by LinKinVax's core shareholders and business angels and will enable LinKinVax to accelerate the clinical development of its innovative protein-based vaccine platform, which can be tweaked to changes and mutations in target pathogens. LinKinVax has already risen to prominence in the French sector, with Bpifrance granting it €31 million under a Covid-related PIA PSCP program and Government ”Plan Relance” , in May 2021. LinKinVax's ...

LinKinVax news
Finsmes 11.02.2022
LinkinVax Raises $4.35M in Seed Funding

Backers included André- Jacques Auberton- Hervé (co-founder and CEO of LinKinVax ), Jean-Paul Kress (CEO of Morphosys), Geoffrey Duyk (US biotechnology entrepreneur and investor), Giorgio Anania, Rémi Gaston- Dreyfus and Alain Tingaud (recognized entrepreneurs in the high-tech sector). The company intends to use the funds to accelerate the clinical development of its protein-based vaccine platform, which can be tweaked to changes and mutations ...